Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC.
Li C, Guan R, Li W, Wei D, Cao S, Chang F, Wei Q, Wei R, Chen L, Xu C, et al. BMC Cancer. 2023 Sep 7; 23(1):840. Epub 2023 Sep 7.